Imunon, Inc. Quarterly Return On Equity in % from Q4 2011 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Imunon, Inc. quarterly/annual Return On Equity history and growth rate from Q4 2011 to Q3 2024.
  • Imunon, Inc. Return On Equity for the quarter ending September 30, 2024 was -230 %, a 97.3% decline year-over-year.
  • Imunon, Inc. annual Return On Equity for 2023 was -98 %, a 12% decline from 2022.
  • Imunon, Inc. annual Return On Equity for 2022 was -87.6 %, a 147% decline from 2021.
  • Imunon, Inc. annual Return On Equity for 2021 was -35.5 %, a 67.9% increase from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -230 -113 -97.3% Jul 1, 2024 Sep 30, 2024
Q2 2024 -166 -62.8 -61.1% Apr 1, 2024 Jun 30, 2024
Q1 2024 -123 -36.7 -42.8% Jan 1, 2024 Mar 31, 2024
Q4 2023 -98 -10.5 -12% Oct 1, 2023 Dec 31, 2023
Q3 2023 -117 -60.1 -107% Jul 1, 2023 Sep 30, 2023
Q2 2023 -103 -52.6 -105% Apr 1, 2023 Jun 30, 2023
Q1 2023 -85.9 -40.6 -89.5% Jan 1, 2023 Mar 31, 2023
Q4 2022 -87.6 -52.1 -147% Oct 1, 2022 Dec 31, 2022
Q3 2022 -56.5 -16.8 -42.2% Jul 1, 2022 Sep 30, 2022
Q2 2022 -50.2 +6.69 +11.8% Apr 1, 2022 Jun 30, 2022
Q1 2022 -45.3 +30.6 +40.3% Jan 1, 2022 Mar 31, 2022
Q4 2021 -35.5 +75.1 +67.9% Oct 1, 2021 Dec 31, 2021
Q3 2021 -39.7 +77.5 +66.1% Jul 1, 2021 Sep 30, 2021
Q2 2021 -56.9 +50.9 +47.2% Apr 1, 2021 Jun 30, 2021
Q1 2021 -76 +44.2 +36.8% Jan 1, 2021 Mar 31, 2021
Q4 2020 -111 -14.7 -15.3% Oct 1, 2020 Dec 31, 2020
Q3 2020 -117 -74 -171% Jul 1, 2020 Sep 30, 2020
Q2 2020 -108 -68.7 -176% Apr 1, 2020 Jun 30, 2020
Q1 2020 -120 -69.1 -135% Jan 1, 2020 Mar 31, 2020
Q4 2019 -96 -35.6 -59% Oct 1, 2019 Dec 31, 2019
Q3 2019 -43.2 +57.3 +57% Jul 1, 2019 Sep 30, 2019
Q2 2019 -39.1 +80.1 +67.2% Apr 1, 2019 Jun 30, 2019
Q1 2019 -51.1 +75.6 +59.7% Jan 1, 2019 Mar 31, 2019
Q4 2018 -60.4 +122 +66.9% Oct 1, 2018 Dec 31, 2018
Q3 2018 -101 +253 +71.6% Jul 1, 2018 Sep 30, 2018
Q2 2018 -119 +182 +60.4% Apr 1, 2018 Jun 30, 2018
Q1 2018 -127 +88.7 +41.2% Jan 1, 2018 Mar 31, 2018
Q4 2017 -182 -2.79 -1.55% Oct 1, 2017 Dec 31, 2017
Q3 2017 -354 -212 -150% Jul 1, 2017 Sep 30, 2017
Q2 2017 -301 -198 -191% Apr 1, 2017 Jun 30, 2017
Q1 2017 -215 -121 -129% Jan 1, 2017 Mar 31, 2017
Q4 2016 -180 -90.9 -102% Oct 1, 2016 Dec 31, 2016
Q3 2016 -141 -59 -71.6% Jul 1, 2016 Sep 30, 2016
Q2 2016 -104 -21.9 -26.8% Apr 1, 2016 Jun 30, 2016
Q1 2016 -94.2 -18.9 -25.1% Jan 1, 2016 Mar 31, 2016
Q4 2015 -88.7 -24 -37.2% Oct 1, 2015 Dec 31, 2015
Q3 2015 -82.3 -23.5 -40% Jul 1, 2015 Sep 30, 2015
Q2 2015 -81.8 -26.9 -49% Apr 1, 2015 Jun 30, 2015
Q1 2015 -75.3 -36.5 -94% Jan 1, 2015 Mar 31, 2015
Q4 2014 -64.7 -38.5 -147% Oct 1, 2014 Dec 31, 2014
Q3 2014 -58.8 -11.6 -24.5% Jul 1, 2014 Sep 30, 2014
Q2 2014 -54.9 +9.39 +14.6% Apr 1, 2014 Jun 30, 2014
Q1 2014 -38.8 +78.3 +66.8% Jan 1, 2014 Mar 31, 2014
Q4 2013 -26.2 +151 +85.2% Oct 1, 2013 Dec 31, 2013
Q3 2013 -47.2 +84.6 +64.2% Jul 1, 2013 Sep 30, 2013
Q2 2013 -64.3 +60.7 +48.6% Apr 1, 2013 Jun 30, 2013
Q1 2013 -117 +40 +25.5% Jan 1, 2013 Mar 31, 2013
Q4 2012 -177 +55.5 +23.8% Oct 1, 2012 Dec 31, 2012
Q3 2012 -132 Jul 1, 2012 Sep 30, 2012
Q2 2012 -125 Apr 1, 2012 Jun 30, 2012
Q1 2012 -157 Jan 1, 2012 Mar 31, 2012
Q4 2011 -233 Oct 1, 2011 Dec 31, 2011
* An asterisk sign (*) next to the value indicates that the value is likely invalid.